Prometheus Laboratories Inc. Files for Up to $100 Million IPO

Prometheus Laboratories, based in San Diego, is a specialty pharmaceutical company integrating therapeutics and clinical information services for the optimal management of gastrointestinal, rheumatological and other autoimmune diseases and disorders and has filed for an IPO. (read full story at: biospace.com)